The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Inhibition of Interleukin-1 by Anakinra Improves Vascular and Left Ventricular Function in Patients With Rheumatoid Arthritis
Abstract
Background—Interleukin-1 increases nitrooxidative stress. We investigated the effects of a human recombinant interleukin-1a receptor antagonist (anakinra) on nitrooxidative stress and vascular and left ventricular function. Methods and Results—In an acute, double-blind trial, 23 patients with rheumatoid arthritis were randomized to receive a single injection of anakinra (150 mg SC) or placebo and, after 48 hours, the alternative treatment. At baseline and 3 hours after the injection, we assessed (1) coronary flow reserve, aortic distensibility, systolic and diastolic (Em) velocity of the mitral annulus, and E to Em ratio (E/Em) using echocardiography; (2) flow-mediated, endothelium-dependent dilation of the brachial artery; and (3) malondialdehyde, nitrotyrosine, interleukin-6, endothelin-1, and C-reactive protein. In a chronic, nonrandomized trial, 23 patients received anakinra and 19 received prednisolone for 30 days, after which all indices were reassessed. Compared with baseline, there was a greater reduction in malondialdehyde, nitrotyrosine, interleukin-6, and endothelin-1 and a greater increase in flow-mediated dilation, coronary flow reserve, aortic distensibility, systolic velocity of mitral annulus, and E/Em after anakinra than after placebo (malondialdehyde −25% versus 9%; nitrotyrosine −38% versus −11%; interleukin-6 −29% versus 0.9%; endothelin-1 −36% versus −11%; flow-mediated dilation 45% versus −9%; coronary flow reserve 29% versus 4%; and aortic distensibility 45% versus 2%;P<0.05 for all comparisons). After 30 days of treatment, the improvement in biomarkers and in vascular and left ventricular function was greater in the anakinra group than in the prednisolone group (P<0.05). Conclusions—Interleukin-1 inhibition improves vascular and left ventricular function and is associated with reduction of nitrooxidative stress and endothelin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arnett, F. C., Edworthy, S. M., Bloch, D. A., Mcshane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,752
Nagueh, S. F., Middleton, K. J., Kopelen, H. A., Zoghbi, W. A., & Quiñones, M. A. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00344-6 · Cited by 3,029
McDonald's blood flow in arteries; theoretical, experimental and clinical principles
(1992) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(92)90079-y · Cited by 2,388
Interleukin-1 and interleukin-1 antagonism
Dinarello, C. (1991) · Blood · doi:10.1182/blood.v77.8.1627.1627 · Cited by 2,304
Kaur, H., & Halliwell, B. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00722-5 · Cited by 706
Hürlimann, D., Forster, A., Noll, G., Enseleit, F., Chenevard, R., Distler, O., Béchir, M., Spieker, L. E., Neidhart, M., Michel, B. A., et al. (2002) · Circulation · doi:10.1161/01.cir.0000037521.71373.44 · Cited by 574
IL-1 stimulates IL-6 production in endothelial cells.
Sironi, M., Breviario, F., Proserpio, P., Biondi, A., Vecchi, A., Van Damme, J., Dejana, E., & Mantovani, A. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.2.549 · Cited by 521
Nitric Oxide Regulates Local Arterial Distensibility In Vivo
Wilkinson, I. B., Qasem, A., McEniery, C. M., Webb, D. J., Avolio, A. P., & Cockcroft, J. R. (2002) · Circulation · doi:10.1161/hc0202.101970 · Cited by 502
Mäki-Petäjä, K. M., Hall, F. C., Booth, A. D., Wallace, S. M. L., Yasmin, Bearcroft, P. W. P., Harish, S., Furlong, A., McEniery, C. M., Brown, J., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.601641 · Cited by 416
Fleischmann, R. M., Schechtman, J., Bennett, R., Handel, M. L., Burmester, G., Tesser, J., Modafferi, D., Poulakos, J., & Sun, G. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10870 · Cited by 392
A Tale of Two Diseases: Atherosclerosis and Rheumatoid Arthritis
Pasceri, V., & Yeh, E. T. H. (1999) · Circulation · doi:10.1161/01.cir.100.21.2124 · Cited by 377
The Elastic Properties of the Arterial Wall
Roy, C. S. (1881) · The Journal of Physiology · doi:10.1113/jphysiol.1881.sp000088 · Cited by 343
Biochemistry of protein tyrosine nitration in cardiovascular pathology
PELUFFO, G., & RADI, R. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.04.024 · Cited by 291
Weinstein, D. M., Mihm, M. J., & Bauer, J. A. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39082-2 · Cited by 229
Furst, D. E. (2004) · Clinical Therapeutics · doi:10.1016/j.clinthera.2004.12.019 · Cited by 171
Short- and Long-Term COX-2 Inhibition Reverses Endothelial Dysfunction in Patients With Hypertension
Widlansky, M. E., Price, D. T., Gokce, N., Eberhardt, R. T., Duffy, S. J., Holbrook, M., Maxwell, C., Palmisano, J., Keaney, J. F., Morrow, J. D., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000084603.93510.28 · Cited by 158
Cardiovascular disease in rheumatoid arthritis
Kaplan, M. J. (2006) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000218951.65601.bf · Cited by 135
Hildick‐Smith, D., & Shapiro, L. M. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00947-5 · Cited by 126
Investigation of protein oxidation and lipid peroxidation in patients with rheumatoid arthritis
Başkol, G., Demir, H., Başkol, M., Kılıç, E., Ates, F., Karakükçü, Ç., & Üstdal, M. (2005) · Cell Biochemistry and Function · doi:10.1002/cbf.1257 · Cited by 95
Zou, M., Jendral, M. J., & Ullrich, V. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702434 · Cited by 93
Nitrosative Capacity of Macrophages Is Dependent on Nitric-oxide Synthase Induction Signals
Espey, M. G., Miranda, K. M., Pluta, R. M., & Wink, D. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.11341 · Cited by 92
Ikonomidis, I., Lekakis, J. P., Stamatelopoulos, K. S., Markomihelakis, N., Kaklamanis, P. G., & Mavrikakis, M. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.10.042 · Cited by 89
Self-citationHaruna, Y., Morita, Y., Komai, N., Yada, T., Sakuta, T., Tomita, N., Fox, D. A., & Kashihara, N. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21891 · Cited by 87
Okada, H., Woodcock‐Mitchell, J., Mitchell, J., Sakamoto, T., Marutsuka, K., Sobel, B. E., & Fujii, S. (1998) · Circulation · doi:10.1161/01.cir.97.21.2175 · Cited by 84
Ikonomidis, I., Athanassopoulos, G. D., Lekakis, J. P., Venetsanou, K., Marinou, M., Stamatelopoulos, K. S., Cokkinos, D. V., & Nihoyannopoulos, P. (2005) · Circulation · doi:10.1161/circulationaha.104.532259 · Cited by 84
Self-citationProperties of the Arterial Wall
Nichols, W. W. (2022) · CRC Press eBooks · doi:10.1201/9781351253765-4 · Cited by 79
Hozumi, T., Eisenberg, M. S., Sugioka, K., Kokkirala, A. R., Watanabe, H., Teragaki, M., Yoshikawa, J., & Homma, S. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-7-200204020-00009 · Cited by 48
Coopamah, M. D., Freedman, J. J., & Semple, J. W. (2003) · Blood · doi:10.1182/blood-2003-04-1029 · Cited by 47
Leff, J. A., Bodman, M. E., Cho, O. J., et al. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.1.8025734 · Cited by 46
Takagi, A., Tsurumi, Y., Ishizuka, N., Omori, H., Arai, K., Hagiwara, N., & Kasanuki, H. (2006) · Heart and Vessels · doi:10.1007/s00380-006-0905-5 · Cited by 16
Takahashi, T., Nishizawà, Y., Hato, F., et al. (2006) · Microvascular Research · doi:10.1016/j.mvr.2006.08.002 · Cited by 14
Gui, Y., Zheng, X., & Hollenberg, M. D. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.2.h566 · Cited by 13
Coppola, A., Astarita, C., Liguori, E., Fontana, D., Oliviero, M., Esposito, K., Coppola, L., & Giugliano, D. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01389.x · Cited by 12
Gravellese (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200002)43:2 · Cited by 2
Cited by
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
Dinarello, C. A., Simon, A., & van der Meer, J. W. M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3800 · Cited by 1,768
Cavalli, G., De Luca, G., Campochiaro, C., Della-Torre, E., Ripa, M., Canetti, D., Oltolini, C., Castiglioni, B., Tassan Din, C., Boffini, N., et al. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30127-2 · Cited by 970
Ridker, P. M., Thuren, T., Zalewski, A., & Libby, P. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.06.012 · Cited by 799
Interleukins, from 1 to 37, and interferon-γ: Receptors, functions, and roles in diseases
Akdis, M., Burgler, S., Crameri, R., Eiwegger, T., Fujita, H., Gomez, E., Klunker, S., Meyer, N., O’Mahony, L., Palomares, O., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.050 · Cited by 778
Murphy, S. P., Kakkar, R., McCarthy, C. P., & Januzzi, J. L. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.01.014 · Cited by 738
Metadata
- Authors
- Ikonomidis, I., Lekakis, J. P., Nikolaou, M., Paraskevaidis, I., Andreadou, I., Kaplanoglou, T., Katsimbri, P., Skarantavos, G., Soucacos, P. N., & Kremastinos, D. T.
- Venue
- Circulation
- Published
- 2008-05-20
- Volume
- 117
- Issue
- 20
- Pages
- 2662-2669
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2042227371
- Cited by
- 307
- References
- 35
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.